Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac versus hyoscine for pain control in renal colic
IRCT20100102002954N19Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ketorolac and scopolamine in Renal colic (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoint: Reduction in severity of kidney pain. Started Jul 2020; status: completed.
02
Drugs
ketorolacscopolamine
03
Conditions
Renal colic
Beyond the preview
Go deeper on IRCT20100102002954N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002954N19.